OBJECTIVE: Inflammation may play a pathogenic role in chronic heart failure (CHF). The objective of the study was to characterise the imbalance in the cytokine network in CHF. METHODS: cDNA expression arrays were used to analyse the gene expression of cytokines and related mediators in peripheral blood mononuclear cells (PBMC) from CHF patients (n=8) and healthy controls (n=8). Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the gene expression of individual genes in additional 12 patients and eight controls. RESULTS: From 375 genes, 34 were upregulated and two downregulated in CHF patients in the cDNA expression array experiments. Regulated genes included chemokines/-receptors, members of the transforming growth factor beta superfamily, orphan receptors and in particular several members of the tumor necrosis factor (TNF) superfamily. Thus, 4-1BB ligand (L), APRIL, CD27L, CD40L, FasL, LIGHT, TRAIL-receptor 4 were upregulated, while TRAIL-receptor 3 was downregulated. Real-time quantitative RT-PCR confirmed significantly upregulated gene expression of APRIL, LIGHT, FasL and CD27L in CHF patients and showed in addition significantly enhanced gene expression of TNFalpha and TRAIL. CONCLUSION: The present study demonstrates differential gene expression in PBMC of several members of the cytokine network in CHF. In particular, the enhanced expression of several ligands in the TNF superfamily may reflect a potential pathogenic role of these cytokines in CHF.
OBJECTIVE: Inflammation may play a pathogenic role in chronic heart failure (CHF). The objective of the study was to characterise the imbalance in the cytokine network in CHF. METHODS: cDNA expression arrays were used to analyse the gene expression of cytokines and related mediators in peripheral blood mononuclear cells (PBMC) from CHFpatients (n=8) and healthy controls (n=8). Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the gene expression of individual genes in additional 12 patients and eight controls. RESULTS: From 375 genes, 34 were upregulated and two downregulated in CHFpatients in the cDNA expression array experiments. Regulated genes included chemokines/-receptors, members of the transforming growth factor beta superfamily, orphan receptors and in particular several members of the tumor necrosis factor (TNF) superfamily. Thus, 4-1BB ligand (L), APRIL, CD27L, CD40L, FasL, LIGHT, TRAIL-receptor 4 were upregulated, while TRAIL-receptor 3 was downregulated. Real-time quantitative RT-PCR confirmed significantly upregulated gene expression of APRIL, LIGHT, FasL and CD27L in CHFpatients and showed in addition significantly enhanced gene expression of TNFalpha and TRAIL. CONCLUSION: The present study demonstrates differential gene expression in PBMC of several members of the cytokine network in CHF. In particular, the enhanced expression of several ligands in the TNF superfamily may reflect a potential pathogenic role of these cytokines in CHF.
Authors: Arne Yndestad; Jan Kristian Damås; Erik Oie; Thor Ueland; Lars Gullestad; Pål Aukrust Journal: Heart Fail Rev Date: 2006-03 Impact factor: 4.214
Authors: Ivan C Gerling; Robert A Ahokas; German Kamalov; Wenyuan Zhao; Syamal K Bhattacharya; Yao Sun; Karl T Weber Journal: JACC Heart Fail Date: 2013-12-01 Impact factor: 12.035
Authors: E Stylianou; V Bjerkeli; A Yndestad; L Heggelund; T Waehre; J K Damås; P Aukrust; S S Frøland Journal: Clin Exp Immunol Date: 2003-06 Impact factor: 4.330
Authors: Robert A Ahokas; Kenneth J Warrington; Ivan C Gerling; Yao Sun; Linus A Wodi; Paula A Herring; Li Lu; Syamal K Bhattacharya; Arnold E Postlethwaite; Karl T Weber Journal: Circ Res Date: 2003-10-23 Impact factor: 17.367
Authors: V Eskandari; A A Amirzargar; M J Mahmoudi; Z Rahnemoon; F Rahmani; S Sadati; Z Rahmati; F Gorzin; M Hedayat; N Rezaei Journal: Ir J Med Sci Date: 2017-09-09 Impact factor: 1.568